Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $51.02 $63.08 Friday, 10th May 2024 CRSP stock ended at $51.17. This is 4.44% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 7.59% from a day low at $51.02 to a day high of $54.89.
90 days $51.02 $91.10
52 weeks $37.55 $91.10

Historical CRISPR Therapeutics AG prices

Date Open High Low Close Volume
Feb 29, 2024 $89.39 $89.88 $83.04 $84.22 2 513 430
Feb 28, 2024 $88.24 $90.62 $87.32 $87.68 2 105 423
Feb 27, 2024 $87.11 $89.61 $84.66 $89.12 2 585 979
Feb 26, 2024 $83.49 $86.84 $83.25 $86.06 2 206 884
Feb 23, 2024 $85.93 $87.69 $82.35 $83.99 2 042 770
Feb 22, 2024 $82.00 $91.10 $81.83 $86.19 4 278 275
Feb 21, 2024 $82.49 $83.50 $77.11 $82.41 3 107 508
Feb 20, 2024 $80.24 $82.00 $77.80 $78.73 2 168 165
Feb 16, 2024 $83.73 $84.89 $81.92 $82.22 2 190 901
Feb 15, 2024 $79.75 $90.18 $79.28 $84.48 5 992 320
Feb 14, 2024 $74.55 $79.95 $73.34 $79.04 4 123 757
Feb 13, 2024 $72.39 $75.15 $71.89 $72.78 3 191 453
Feb 12, 2024 $70.03 $76.48 $69.80 $76.44 2 937 523
Feb 09, 2024 $69.73 $72.48 $69.36 $70.01 2 530 321
Feb 08, 2024 $65.60 $69.33 $64.16 $68.83 1 964 508
Feb 07, 2024 $67.00 $67.21 $65.60 $65.72 1 298 075
Feb 06, 2024 $64.41 $66.90 $63.58 $66.88 1 686 877
Feb 05, 2024 $64.00 $64.82 $62.47 $64.51 938 966
Feb 02, 2024 $62.90 $65.13 $62.09 $64.75 1 472 347
Feb 01, 2024 $63.49 $65.80 $62.20 $64.67 1 447 393
Jan 31, 2024 $63.99 $66.13 $62.75 $62.95 1 356 397
Jan 30, 2024 $65.08 $65.67 $63.91 $64.48 1 190 433
Jan 29, 2024 $61.08 $65.96 $60.02 $65.78 2 214 811
Jan 26, 2024 $63.41 $64.38 $60.81 $61.01 1 609 691
Jan 25, 2024 $62.87 $64.15 $62.45 $62.87 1 461 438
Click to get the best stock tips daily for free!

About CRISPR Therapeutics AG

CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA. The company has a portfolio of therapeutic programs across a range of disease areas, including hemoglo... CRSP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT